Anastasios Kyriazoglou

1.0k total citations
60 papers, 610 citations indexed

About

Anastasios Kyriazoglou is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Anastasios Kyriazoglou has authored 60 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Anastasios Kyriazoglou's work include Sarcoma Diagnosis and Treatment (26 papers), Vascular Tumors and Angiosarcomas (9 papers) and Cancer Genomics and Diagnostics (8 papers). Anastasios Kyriazoglou is often cited by papers focused on Sarcoma Diagnosis and Treatment (26 papers), Vascular Tumors and Angiosarcomas (9 papers) and Cancer Genomics and Diagnostics (8 papers). Anastasios Kyriazoglou collaborates with scholars based in Greece, United States and United Kingdom. Anastasios Kyriazoglou's co-authors include Meletios Α. Dimopoulos, Michalis Liontos, Aristotelis Bamias, Flora Zagouri, Roubini Zakopoulou, Amanda Psyrri, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Panagiota Economopoulou and Eleni Zografos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncogene.

In The Last Decade

Anastasios Kyriazoglou

52 papers receiving 605 citations

Peers

Anastasios Kyriazoglou
Malti Kshirsagar United States
Shih-Chen Yu Taiwan
Mana Taki Japan
Magdalena Chechlińska Poland
Morio Sawada Japan
Maria D. Begnami Brazil
Uwe-Jochen Göhring Germany
Hugo Prazeres Portugal
Malti Kshirsagar United States
Anastasios Kyriazoglou
Citations per year, relative to Anastasios Kyriazoglou Anastasios Kyriazoglou (= 1×) peers Malti Kshirsagar

Countries citing papers authored by Anastasios Kyriazoglou

Since Specialization
Citations

This map shows the geographic impact of Anastasios Kyriazoglou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anastasios Kyriazoglou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anastasios Kyriazoglou more than expected).

Fields of papers citing papers by Anastasios Kyriazoglou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anastasios Kyriazoglou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anastasios Kyriazoglou. The network helps show where Anastasios Kyriazoglou may publish in the future.

Co-authorship network of co-authors of Anastasios Kyriazoglou

This figure shows the co-authorship network connecting the top 25 collaborators of Anastasios Kyriazoglou. A scholar is included among the top collaborators of Anastasios Kyriazoglou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anastasios Kyriazoglou. Anastasios Kyriazoglou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kotsantis, Ioannis, Aristotelis Kalyvas, Anastasios Kyriazoglou, et al.. (2025). Artificial Intelligence in the Diagnosis and Treatment of Brain Gliomas. Biomedicines. 13(9). 2285–2285.
2.
Kotsantis, Ioannis, et al.. (2025). Percutaneous Cryoneurolysis of Splanchnic Nerves for Pain Palliation in Patients with Pancreatic Cancer: A Single-Center Experience. CardioVascular and Interventional Radiology. 48(10). 1438–1446.
3.
Koutsoukos, Konstantinos, Roubini Zakopoulou, Kimon Tzannis, et al.. (2024). 1961O Nivolumab plus chemoradiotherapy in patients with non-metastatic muscle-invasive bladder cancer (nmMIBC), not undergoing cystectomy: A phase II, randomized study by the Hellenic GU Cancer Group. Annals of Oncology. 35. S1133–S1134. 2 indexed citations
4.
Koufopoulos, Nektarios, Abraham Pouliakis, Ioannis Boutas, et al.. (2024). Primary and Metastatic Pancreatic Ewing Sarcomas: A Case Report and Review of the Literature. Diagnostics. 14(23). 2694–2694. 1 indexed citations
5.
Liontos, Michalis, Evangelos Bournakis, Vassiliki Zolota, et al.. (2024). Real-World Treatment Patterns in Patients With Metastatic Castration-Resistant Prostate Cancer in Greece: The PROSPECT Study. Clinical Genitourinary Cancer. 22(6). 102170–102170.
6.
Kyriazoglou, Anastasios, Myrto Moutafi, Eleni Zografos, et al.. (2024). Expression of DNA Repair Genes in Ewing Sarcoma. Cancer Diagnosis & Prognosis. 4(3). 231–238.
7.
Anastasiou, Μaria, Anastasios Kyriazoglou, Ioannis Kotsantis, et al.. (2023). Immune checkpoint inhibitors in sarcomas: a systematic review. Immuno-Oncology Technology. 20. 100407–100407. 9 indexed citations
8.
Riggi, Nicolò, et al.. (2023). Clear cell sarcoma: state-of-the art and perspectives. Expert Review of Anticancer Therapy. 23(3). 235–242. 6 indexed citations
9.
Kokkali, Stefania, Anastasios Kyriazoglou, Panagiota Economopoulou, et al.. (2023). Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers. Journal of Clinical Medicine. 12(3). 1119–1119. 7 indexed citations
10.
Economopoulou, Panagiota, Aris Spathis, Ioannis Kotsantis, et al.. (2023). Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC). Oral Oncology. 139. 106358–106358. 11 indexed citations
11.
Kyriazoglou, Anastasios, Olivier Mir, Bernd Kasper, et al.. (2022). Exploratory analysis of tumor imaging in a Phase 2 trial with cabozantinib in gastrointestinal stromal tumor: lessons learned from study EORTC STBSG 1317 ‘CaboGIST’. Acta Oncologica. 61(6). 663–668. 1 indexed citations
12.
Kyriazoglou, Anastasios, Ioannis Kotsantis, Μaria Anastasiou, et al.. (2021). Systematic Review of Recurrent Osteosarcoma Systemic Therapy. Cancers. 13(8). 1757–1757. 37 indexed citations
13.
Kyriazoglou, Anastasios, Michalis Liontos, Ioannis Ntanasis‐Stathopoulos, & Maria Gavriatopoulou. (2021). The systemic treatment of uterine leiomyosarcomas. Medicine. 100(13). e25309–e25309. 6 indexed citations
14.
Kyriazoglou, Anastasios, et al.. (2020). SHILAP Revista de lepidopterología. 1 indexed citations
15.
Kyriazoglou, Anastasios, Michalis Liontos, Flora Zagouri, et al.. (2020). A Case Series of BCOR Sarcomas With a New Splice Variant of BCOR/CCNB3 Fusion Gene. In Vivo. 34(5). 2947–2954. 6 indexed citations
16.
Kyriazoglou, Anastasios, Roubini Zakopoulou, Flora Zagouri, Aristotelis Bamias, & Meletios Α. Dimopoulos. (2018). Clinical and biological implications of Hippo pathway dysregulation in sarcomas. SHILAP Revista de lepidopterología. 9(1). 11–16.
17.
Kyriazoglou, Anastasios, Michalis Liontos, Dimitrios C. Ziogas, et al.. (2018). Management of uterine sarcomas and prognostic indicators: real world data from a single-institution. BMC Cancer. 18(1). 1247–1247. 29 indexed citations
18.
Kyriazoglou, Anastasios, et al.. (2018). Guillain-Barré Syndrome Related to Nivolumab: Case Report of a Patient With Urothelial Cancer and Review of the Literature. Clinical Genitourinary Cancer. 17(2). e360–e364. 10 indexed citations
19.
Kyriazoglou, Anastasios, et al.. (2012). 12q amplification defines a subtype of extraskeletal osteosarcoma with good prognosis that is the soft tissue homologue of parosteal osteosarcoma. Cancer Genetics. 205(6). 332–336. 12 indexed citations
20.
Kyriazoglou, Anastasios, et al.. (2011). Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas. Cancer Genetics. 204(12). 677–681. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malti Kshirsagar Breakdown of academic impact, for papers by Shih-Chen Yu Breakdown of academic impact, for papers by Mana Taki Breakdown of academic impact, for papers by Magdalena Chechlińska Breakdown of academic impact, for papers by Morio Sawada Breakdown of academic impact, for papers by Maria D. Begnami Breakdown of academic impact, for papers by Uwe-Jochen Göhring Breakdown of academic impact, for papers by Hugo Prazeres
Rankless by CCL
2026